In addition to the immunosuppressive effects of STAT3 in immune cells, work by Wei and colleagues demonstrated that GBM-initiating cells have a constitutively active STAT3 pathway, and that inhibition of STAT3 significantly diminished the ability of these cancer-initiating cells to suppress T-cell expansion and induce Treg recruitment (86). The gene discussed is STAT3; the disease is cancer.